David Wildes

Biochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 10 papers. Top paper: “Concurrent inhibition of oncogenic and wild-type RAS-GTP for cancer therapy”.

Concurrent inhibition of oncogenic and wild-type RAS-GTP for cancer therapy

Nature(2024)10.1038/s41586-024-07205-6

N/A

4.2DataRank · unranked

326 citations

Bianca J. Lee, Jingjing Jiang, Aidan C.A. Tomlinson, Kyle J. Seamon, Alessia Mira +48 more

Chemical remodeling of a cellular chaperone to target the active state of mutant KRAS

Science(2023)10.1126/science.adg9652

N/A

4.2DataRank · unranked

237 citations

Kyle J. Seamon, Yulei Zhao, Yu Chi Yang, Jim Cregg, Dong-Sung Kim +31 more

Tumour-selective activity of RAS-GTP inhibition in pancreatic cancer

Nature(2024)10.1038/s41586-024-07379-z

N/A

3.9DataRank · unranked

182 citations

Jingjing Jiang, Tanner C. Dalton, Álvaro Curiel‐García, A. Cole Edwards, Yingyun Wang +61 more

Tumor-selective effects of active RAS inhibition in pancreatic ductal adenocarcinoma

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.12.03.569791

N/A

0.373DataRank · unranked

11 citations

Jingjing Jiang, Alvaro Curiel-Garcia, Yingyun Wang, Bianca J. Lee, Margo Orlen +42 more

Concurrent inhibition of oncogenic and wild-type RAS-GTP for cancer therapy

10.21203/rs.3.rs-3122478/v1

N/A

0.292DataRank · unranked

6 citations

Matthew Holderfield, Bianca Lee, Jingjing Jiang, Aidan Tomlinson, Kyle Seamon +44 more

Author Correction: Selective inhibitors of mTORC1 activate 4EBP1 and suppress tumor growth

Nature Chemical Biology(2021)10.1038/s41589-021-00843-1

N/A

0DataRank · unranked

2 citations

Jacob A. Boyer, G. Leslie Burnett, Arun P. Thottumkara, Nidhi Tibrewal, Stacy Wilson +21 more

Efficacy of a Novel Bi-Steric mTORC1 Inhibitor in Models of B-Cell Acute Lymphoblastic Leukemia

Frontiers in Oncology(2021)10.3389/fonc.2021.673213

N/A

0DataRank · unranked

18 citations

Sharmila Mallya, Nuntana Dinglasan, Amos Fung, Tram Nguyen, Lee-or Herzog +7 more

Combined inhibition of KRASG12C and mTORC1 kinase is synergistic in non-small cell lung cancer

Nature Communications(2024)10.1038/s41467-024-50063-z

N/A

0DataRank · unranked

35 citations

Philip H. Choi, Yu Chi Yang, Jacob A. Boyer, Adele Whaley, Priya Pancholi +16 more

Concurrent inhibition of oncogenic and wild-type RAS-GTP for cancer therapy

UNC Libraries(2024)10.17615/1fr6-tv06

N/A

0DataRank · unranked

0 citations

Nicole Nasholm, Chiara Ambrogio, Anthony N. Milin, Yang Liu, Elsa Quintana +48 more

Shp1 Loss Enhances Macrophage Effector Function and Promotes Anti-Tumor Immunity

Frontiers in Immunology(2020)10.3389/fimmu.2020.576310

N/A

0DataRank · unranked

47 citations

Clare L. Abram, David Wildes, Amira Belwafa, Alia M. N. Welsh, Christopher J. Schulze +11 more